<TEXT>&#2;<DATELINE>2020-03-12</DATELINE><TITLE>A human monoclonal antibody blocking SARS-CoV-2 infection</TITLE><BODY>AbstractThe emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV). This cross-neutralizing antibody targets a communal epitope on these viruses and offers potential for prevention and treatment of COVID-19.&#3;</BODY></TEXT>